Susan Abushakra, Vice President of Global Development, Program Lead for Alzheimer’s Disease at Elan Pharmaceuticals, to Give Featured Presentation at 5th Neurodegenerative Conditions Research and Development (Sept 22-23, 2011 in San Francisco)
Susan Abushakra, Vice President of Global Development, Program Lead for Alzheimer’s Disease at Elan Pharmaceuticals will give a featured presentation on “ELND005 (Scyllo-inositol) an Amyloid Anti-aggregation Agent: What We Learned in Phase 2 Studies” at the 5th Neurodegenerative Conditions Research and Development Conference to be held in San Francisco, CA on September 22-23, 2011 by GTC.
View full press release